Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

Details for Australian Patent Application No. 2005300734 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Thierauch, Karl-Heinz; Hess-Stumpp, Holger; Bohlmann, Rolf; Huth, Andreas; Kruger, Martin; Haberey, Martin; Ince, Stuart

Agent Davies Collison Cave

Pub. Number AU-A-2005300734

PCT Pub. Number WO2006/048249

Priority 04090420.3 03.11.04 EP

Filing date 28 October 2005

Wipo publication date 11 May 2006

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/048249 Priority application(s): WO2006/048249

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300735-Multimodal polyethylene composition for pipes

2005300733-Novel anthranilamide pyridinureas as VEGF receptor kinase imhibitors